medigraphic.com

2016, Number S2

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2016; 54 (S2)

Clinical and biochemical characteristics of patients with morbid obesity at the time of hospital admission and one year after undergoing bariatric surgery

Molina-Ayala M, Rodríguez-González A, Albarrán-Sánchez A, Ferreira-Hermosillo A, Ramírez-Rentería C, Luque-de León E, Bosco-Garate I, Laredo-Sánchez F, Contreras-Herrera R, Gregor-Gooch JM, Cuevas-García C, Mendoza-Zubieta V

Language: Spanish
References: 21
Page: 118-123
PDF size: 288.76 Kb.


ABSTRACT

Background: Three percent of Mexicans suffer from morbid obesity. Comorbidities associated to this condition diminish quality of life, increase mortality and health care costs. Despite bariatric surgery has specific indications and risks, it is the only treatment with effective longterm results. The aim of the study was to evaluate biochemical and clinical patient characteristics, both preoperatively and a year after they underwent bariatric surgery.
Methods: We carried out a quasi-experimental study that evaluates a sample of patients in the Clínica de Obesidad at Hospital de Especialidades (a third level hospital) between March 2011 and October 2015.
Results: A total of 150 patients were analyzed (60 % were women). Mean age was 41 ± 9 years and mean body mass index (BMI) was 48 kg/m2 (42-53 kg/m2). Before surgery, type 2 diabetes mellitus (T2DM) was present in 31 %, hypertension in 60 % and 30 % of the patients were “metabolically healthy obese”. A year after surgery, the percentage of excess body weight loss was 66 %, T2DM and hypertension remission was 70 % and 50 %, respectively.
Conclusion: Bariatric surgery is an effective treatment to reduce excess weight. It improves biochemical, and clinical parameters in extreme obese patients.


REFERENCES

  1. Barquera S, Campos-Nonato I, Hernandez-Barrera L, Pedroza A, Rivera-Dommarco JA. Prevalence of obesity in Mexican adults 2000-2012. Salud Publica Mex. 2013;55 (suppl 2):S151-60.

  2. Rubio M, Martínez C, Vidal O, Larrad A, Salas- Salvadó J, Pujol J et al. Documento de consenso sobre cirugía bariátrica. Rev Esp Obes. 2004;4:223-49.

  3. Chang CY, Hung CK, Chang YY, Tai CM, Lin JT, Wang JD. Health-related quality of life in adult patients with morbid obesity coming for bariatric surgery. Obes Surg. 2010;20(8):1121-7.

  4. Rivas A, Ocejo S. Sierra M. Evaluación de la calidad de vida en pacientes sometidos a cirugía de obesidad mórbida. Medicina Universitaria. 2009;11(45):243-6.

  5. Food and Agriculture Organization of the United Nations (FAO), International Fund for Agricultural Development (IFAD) and World Food Program (WFP). The State of Food Insecurity in the World 2013. The multiple dimensions of food security. Rome: FAO; 2013.

  6. Organisation for Economic Co-operation and Development (OECD). Obesity Update 2012. Disponible en http://www.oecd.org/ health/49716427.pdf

  7. Malik VS, Willett WC, Hu FB. Global obesity: trends, risk factors and policy implications. Nat Rev Endocrinol. 2013;9(1):13-27.

  8. Latnovic L, Rodríguez Cabrera L. Public health strategy against overweight and obesity in Mexico's National Agreement for Nutritional Health. Int J Obes Suppl. 2013;3:S12-14.

  9. Barrera-Cruz A, Rodríguez-González A, Molina- Ayala MA. Escenario actual de la obesidad en Mexico. Rev Med Inst Mex Seguro Soc. 2013;51(3):292-9.

  10. [No authors listed]. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253.

  11. World Health Organization. Obesity and overweight 2015 [Updated January 2015]. Fact sheet N° 311. Disponible en http://www.who.int/mediacentre/ factsheets/fs311/en/

  12. Secretaría de Salud. Acuerdo Nacional para la Salud Alimentaria. Estrategia contra el sobrepeso y la obesidad. Distrito Federal, México: Secretaría de Salud; 2010. Disponible en http://activate.gob. mx/Documentos/ACUERDO%20NACIONAL%20 POR%20LA%20SALUD%20ALIMENTARIA.pdf

  13. Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, et al.; Endocrine Society. Pharmacological management of obesity: an endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015 Feb;100(2):342-62. doi: 10.1210/jc.2014-3415.

  14. Sjöström L. Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study. Int J Obes (Lond). 2008 Dec;32 Suppl 7:S93-7. doi: 10.1038/ijo.2008.244.

  15. Sawaya RA, Jaffe J, Friedenberg L, Friedenberg FK. Vitamin, mineral, and drug absorption following bariatric surgery. Curr Drug Metab. 2012 Nov;13(9):1345-55.

  16. Jensen MD, Ryan DH, Apovian CM , Ard JD, Comuzzie AG, Donato KA, et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society. 2013 AHA/ACC/ TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014 Jun 24;129(25 Suppl 2):S102-38. doi: 10.1161/01.cir.0000437739.71477.ee.

  17. Reyes-Pérez A, Sánchez-Aguilar H, Velázquez- Fernández D, Rodríguez-Ortíz D, Mosti M, Herrera MF. Analysis of Causes and Risk Factors for Hospital Readmission After Roux-en-Y Gastric Bypass. Obes Surg. 2016 Feb;26(2):257-60. doi: 10.1007/ s11695-015-1755-y.

  18. Romero-Ibargüengoitia ME, Lerman-Garber I, Herrera-Hernández MF, Pablo-Pantoja J, Sierra- Salazar M, Lopez-Rosales F, et al. Bypass gástrico laparoscópico en Y de Roux y obesidad mórbida. Experiencia en el Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Rev Invest Clin. 2009;61(3):186-93.

  19. Aguilar-Salinas CA, Olaiz G, Valles V, Torres JM, Gómez-Pérez FJ, Rull JA, et al. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. J Lipid Res. 2001 Aug;42(8):1298-307.

  20. Aguilar-Salinas CA, Canizales-Quinteros S, Rojas-Martínez R, Mehta R, Rodríguez-Guillén R, Ordonez-Sánchez ML, et al. The non-synonymous Arg230Cys variant (R230C) of the ATP-binding cassette transporter A1 is associated with low HDL cholesterol concentrations in Mexican adults: a population based nation wide study. Atherosclerosis. 2011;216(1):146-50.

  21. Laing ST, Smulevitz B, Vatcheva KP, Rahbar MH, Reininger B, McPherson DD, et al. Subclinical atherosclerosis and obesity phenotypes among Mexican Americans. J Am Heart Assoc. 2015;4(3):e001540. doi: 10.1161/JAHA.114.001540 Disponible en : http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC4392436/




2020     |     www.medigraphic.com